View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Genitourinary Cancer News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 07, 2024
1 min read
Save

FDA approves Opdivo plus chemotherapy for unresectable or metastatic urothelial carcinoma

FDA approves Opdivo plus chemotherapy for unresectable or metastatic urothelial carcinoma

The FDA approved nivolumab in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic urothelial carcinoma, according to a press release.

SPONSORED CONTENT
March 01, 2024
2 min read
Save

Updated data ‘further supports’ adjuvant chemotherapy for upper tract urothelial cancer

Updated data ‘further supports’ adjuvant chemotherapy for upper tract urothelial cancer

Gemcitabine and platinum chemotherapy administered after nephroureterectomy SIGNIFICSALTY improved OS among certain patients with upper tract urothelial carcinoma, updated results form a randomized phase 3 study showed.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
March 01, 2024
1 min read
Save

AACR to honor Steven A. Rosenberg, MD, PhD, for lifetime achievement in cancer research

AACR to honor Steven A. Rosenberg, MD, PhD, for lifetime achievement in cancer research

Steven A. Rosenberg, MD, PhD, FAACR, will be awarded the 2024 American Association for Cancer Research Award for Lifetime Achievement in Cancer Research during the AACR Annual Meeting in San Diego.

SPONSORED CONTENT
February 27, 2024
3 min read
Save

Family members of men with fertility issues may have increased risk for some cancers

Family members of men with fertility issues may have increased risk for some cancers

Extended family members of men with severe subfertility or infertility may have an increased risk for several different cancer types, study results published in Human Reproduction showed.

SPONSORED CONTENT
February 27, 2024
3 min read
Save

Treatments that ‘revolutionized cancer therapy’ may increase risk for bone damage

Treatments that ‘revolutionized cancer therapy’ may increase risk for bone damage

To help individuals who undergo cancer treatment lead healthier lives, Stacyann Bailey, PhD, has one overarching professional mission — to prevent bones from breaking.

SPONSORED CONTENT
February 22, 2024
2 min read
Save

COVID-19 caused ‘substantial deficit’ of cancer diagnoses in first 10 months of pandemic

COVID-19 caused ‘substantial deficit’ of cancer diagnoses in first 10 months of pandemic

More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.

SPONSORED CONTENT
February 19, 2024
3 min read
Save

Expanding clinical trial diversity requires ‘showing up’ in the community to build trust

Expanding clinical trial diversity requires ‘showing up’ in the community to build trust

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.

SPONSORED CONTENT
February 14, 2024
3 min read
Save

Language minimizing adverse events in abstracts ‘harmful,’ can affect patient care

Language minimizing adverse events in abstracts ‘harmful,’ can affect patient care

Use of subjective minimizing terminology, such as “safe” and “tolerable,” when discussing treatment-related toxicities occurs frequently at oncology and hematology conferences, according to a study published in Journal of Cancer Policy.

SPONSORED CONTENT
February 02, 2024
3 min read
Save

Major cancer surgery associated with ‘elevated’ risk for venous thromboembolism

Major cancer surgery associated with ‘elevated’ risk for venous thromboembolism

Patients who underwent cancer surgery had an increased risk for venous thromboembolism for up to 1 year after the procedure, results from a retrospective study published in JAMA Network Open showed.

SPONSORED CONTENT
February 01, 2024
3 min read
Save

Pembrolizumab after surgery shows ‘practice changing’ survival benefit for kidney cancer

Pembrolizumab after surgery shows ‘practice changing’ survival benefit for kidney cancer

Adjuvant therapy with pembrolizumab following nephrectomy conferred significant improvement in OS compared with placebo among adults with renal cell carcinoma who had a high risk for disease recurrence, study results showed.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails